Janux Therapeutics, Inc. (JANX)

SEC filing

Janux Therapeutics, Inc.

JANX · CIK 1817713

4 · Dec 3, 2025 · Meyer Andrew Hollman sold 3,333 shares at $32.98/share ($109.9K); exercised options for 3,333 shares

Meyer Andrew Hollman sold 3,333 shares at $32.98/share ($109.9K); exercised options for 3,333 shares

xslF345X05/form4-12032025_081207.xml

xslF345X05/form4-12032025_081207.xmlSEC.gov

Graphics and non-inline formats (not embedded below).